<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">IJO</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0301-4738</issn>
      <issn pub-type="epub">1998-3689</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24817751</article-id>
      <article-id pub-id-type="pmc">4064230</article-id>
      <article-id pub-id-type="publisher-id">IJO-62-489</article-id>
      <article-id pub-id-type="doi">10.4103/0301-4738.132110</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Communications</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Multiple extra macular branch retinal vein occlusions in hyperhomocysteinemia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gore</surname>
            <given-names>Abhijit Diwakar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>Girish Shiva</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gore</surname>
            <given-names>Mansi Abhijit</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Desai</surname>
            <given-names>Abhishek R</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Retina, Shree Ganapati Netralaya, Jalna, Maharashtra, India</aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence to:</bold> Dr. Abhijit D. Gore, Department of Retina, Shree Ganapati Netralaya, Jalna, Maharashtra, India. E-mail: <email xlink:href="drabhijit83@gmail.com">drabhijit83@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2014</year>
      </pub-date>
      <volume>62</volume>
      <issue>4</issue>
      <fpage>489</fpage>
      <lpage>491</lpage>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>4</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Indian Journal of Ophthalmology</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Hyperhomocysteinemia is a well-known modifiable risk factor for thromboembolism. Retinal vascular occlusion in patients having hyperhomocysteinemia is a known entity, particularly in young patients. However, multiple extra macular branch retinal vein occlusion (BRVO) is a rare condition, which can be a presentation of this disease. We present a patient who had multiple extra macular BRVO; on complete systemic workup, he was found to have raised homocysteine levels.</p>
      </abstract>
      <kwd-group>
        <kwd>Extra macular BRVO</kwd>
        <kwd>hyperhomocysteinemia</kwd>
        <kwd>multiple BRVO</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Hyperhomocysteinemia is a known risk factor for ocular and systemic vaso-occlusive events.</p>
    <p>However, multiple extra macular branch retinal vein occlusion (BRVOs) has not been mentioned in literature with hyperhomocysteinemia.</p>
    <sec id="sec1-1">
      <title>Case Report</title>
      <p>A 45-year-old man presented with a history of blurred vision in his right eye since past 15 days. He was a known case of bronchial asthma since 6 years. On examination, his right eye best corrected visual acuity was 20/20. Anterior segment examination and IOP was normal.</p>
      <p>Fundus examination showed multiple cotton wool spots inferior to the papillomacular bundle, extending toward macula with retinal hemorrhages temporal to macula [<xref ref-type="fig" rid="F1">Fig. 1</xref>].</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Color fundus photo showing numerous soft exudates in inferotemporal part extending toward macula in some part, multiple vein constrictions, and occlusions</p>
        </caption>
        <graphic xlink:href="IJO-62-489-g001"/>
      </fig>
      <p>Red free and fluorescein angiography [Figs. <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F3">3</xref>] showed areas of blocked fluorescence due to hemorrhages and multiple BRVOs. Macular perfusion was not affected as foveal avascular zone was normal.</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Fuorescein angiography showing multiple branch retinal vein occlusions</p>
        </caption>
        <graphic xlink:href="IJO-62-489-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Asterix and arrows showing partial vein obstructions</p>
        </caption>
        <graphic xlink:href="IJO-62-489-g003"/>
      </fig>
      <p>Optical coherence tomography [Figs. <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4</xref>] showed normal foveal contour and anatomy. Patient underwent complete systemic workup including hemogram with erythrocyte sedimentation rate (ESR), lipid profile, renal function tests, ANA, c-ANCA, p-ANCA, homocysteine levels, coagulation profile (Prothrombin time, APTT, bleeding time, clotting time, protein C and S levels), syphilis serology, echocardiography, and electrocardiogram. Except a raised level of homocysteine (35 &#x3BC;M) (normal range: 5-15 &#x3BC;M), all other levels were within normal limits.</p>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>OCT showing normal anatomy of macula</p>
        </caption>
        <graphic xlink:href="IJO-62-489-g004"/>
      </fig>
      <p>He was started on anticoagulants and homocysteine lowering agents under guidance of an internist. As macular perfusion was not affected and there was no associated cystoid macular edema, no active ocular intervention was done. He was advised close follow-up for early detection of any further vision threatening vein obstruction.</p>
    </sec>
    <sec sec-type="discussion" id="sec1-2">
      <title>Discussion</title>
      <p>Retinal vein occlusion (RVO) is the second most common sight-threatening retinal vascular disorder after diabetic retinopathy. The incidence of BRVO is generally higher than the incidence of CRVO. Patients with RVO have a higher prevalence of stroke and a greater risk of cardiovascular disease than similarly aged individuals without RVO.[<xref rid="ref1" ref-type="bibr">1</xref>]</p>
      <p>BRVO prevalence has been shown to vary from 0.7% to 1.6%. BRVO is divided into two distinct entities: Major BRVO, when one of the major branch retinal veins is occluded, and macular BRVO, when one of the macular venules is occluded. In 66% of eyes with BRVO, there is occlusion of the major branch in the superotemporal quadrant, followed by 22-43% of eyes with occlusion of the major branch in the inferotemporal quadrant. Major BRVO can be asymptomatic or with visual blurring, usually involving the sector of visual field corresponding to the area of the retina involved. In macular BRVO, there is always a central visual disturbance with normal peripheral vision.[<xref rid="ref2" ref-type="bibr">2</xref>]</p>
      <p>Among all conditions leading to a hypercoagulable state, hyperhomocysteinemia was the commonest cause found in 21.9% patients. Homocysteine is an amino acid derived from methionine, which can be converted into cysteine. The metabolic pathways involving homocysteine require vitamin B<sub>12</sub>, vitamin B<sub>6</sub>, and folate for proper functioning. Various reports on hyperhomocysteinemia depict that arterial as well as venous vessels are involved in the disease.[<xref rid="ref3" ref-type="bibr">3</xref>]</p>
      <p>The rare syndrome of homocystinuria was first described in 1962 among subjects with mental retardation, ocular, and skeletal abnormalities, as well as a high risk of thromboembolism.[<xref rid="ref4" ref-type="bibr">4</xref>]</p>
      <p>Increased plasma homocysteine is associated with both RVO and retinal arterial occlusion, the elevation being greater in the arterial occlusion group. In young patients, RVO is less associated with systemic diseases and is more strongly associated with plasma homocysteine than in older patients.</p>
      <p>Atherosclerotic plaques occur in young people with homocystinuria who suffer from premature, aggressive occlusive disease. Plasma concentrations of homocysteine are an independent risk factor for cardiovascular and cerebrovascular disease in the general population.[<xref rid="ref5" ref-type="bibr">5</xref>]</p>
      <p>Mild to moderate elevation of plasma homocysteine is reported as a risk factor for occlusive disease. Specifically, many studies demonstrate hyperhomocysteinemia as an independent risk factor for atherosclerosis in the coronary, cerebral, and peripheral vasculature. The mechanisms by which homocysteinemia damages the blood vessel wall by supporting prothrombotic effects seems to be multifactorial. The various mechanisms reported include homocysteine-induced oxidative stress (redox stress), decreased bioavailability of nitric oxide, altered expression of various thrombotic factors, mutagenic effect on arterial smooth muscle cells, and expression of acute stress-related genes.[<xref rid="ref6" ref-type="bibr">6</xref>]</p>
      <p>Homocysteinemia presenting as multiple extra macular BRVOs has not been cited in literature.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>]</p>
      <p>Patients presenting with such kind of clinical picture should be investigated thoroughly to rule out any modifiable risk factor such as hyperhomocysteinemia to prevent any further vaso-occlusive event.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil.</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laouri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Looman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gallagher</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The burden of disease of retinal vein occlusion: Review of the literature</article-title>
          <source>Eye (Lond)</source>
          <year>2011</year>
          <volume>25</volume>
          <fpage>981</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">21546916</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rehak</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rehak</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Branch retinal vein occlusion: Pathogenesis, visual prognosis, and treatment modalities</article-title>
          <source>Curr Eye Res</source>
          <year>2008</year>
          <volume>33</volume>
          <fpage>111</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">18293182</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ratra</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dhupper</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Retinal arterial occlusions in the young: Systemic associations in Indian population</article-title>
          <source>Indian J Ophthalmol</source>
          <year>2012</year>
          <volume>60</volume>
          <fpage>95</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">22446902</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cahill</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Karabatzaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meleady</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Refsum</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ueland</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease</article-title>
          <source>Br J Ophthalmol</source>
          <year>2000</year>
          <volume>84</volume>
          <fpage>154</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">10655190</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wright</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Dodson</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Homocysteine, folates, and the eye</article-title>
          <source>Eye (Lond)</source>
          <year>2008</year>
          <volume>22</volume>
          <fpage>989</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">18064053</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Narayanasamy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Subramaniam</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Karunakaran</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ranganathan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Shivaramakrishnan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>1441</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">17389469</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vine</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Hyperhomocysteinemia: A new risk factor for central retinal vein occlusion</article-title>
          <source>Trans Am Ophthal Soc</source>
          <year>2000</year>
          <volume>98</volume>
          <fpage>493</fpage>
          <lpage>503</lpage>
          <pub-id pub-id-type="pmid">11190038</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayreh</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Zimmerman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mccarthy</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Podhajsky</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Systemic diseases associated with various types of retinal vein occlusion</article-title>
          <source>Am J Ophthalmol</source>
          <year>2001</year>
          <volume>131</volume>
          <fpage>61</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">11162981</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Marx</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Hollifield</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Dick</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Brozetti</surname>
              <given-names>JJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Homocysteine: A risk factor for retinal venous occlusive disease</article-title>
          <source>Ophthalmology</source>
          <year>2002</year>
          <volume>109</volume>
          <fpage>287</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">11825810</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
